Low-density lipoprotein apheresis is effective in reducing lipoprotein(a) levels and in improving symptoms in a patient with refractory angina secondary to accelerated coronary artery disease

Journal of Clinical Lipidology

Volumn 6, Issue 2, 2012, Pages 192-194

  Ibrahim, Michael ^a   Ussen, Bassey ^a   Pottle, Alison ^a   Barbir, Mahmoud ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Coronary artery disease; Coronary risk; LDL apheresis; Lipoprotein(a); Refractory angina

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAROPIPRANT PLUS NICOTINIC ACID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; APHERESIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DISEASE COURSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FUNCTIONAL STATUS; GENETIC SCREENING; HUMAN; HUMAN TISSUE; IN-STENT RESTENOSIS; LIPOPROTEIN BLOOD LEVEL; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; THORAX PAIN; THYROID FUNCTION TEST; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

ANGINA PECTORIS; BLOOD COMPONENT REMOVAL; CORONARY ARTERY DISEASE; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; MIDDLE AGED;

ANGINA;

EID: 84857923378     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2011.11.003     Document Type: Article

References (7)

1. British Heart Foundation statistics website. Available at: http://www.heartstats org. Accessed December 2, 2011.
2. J. Armitage, L. Bowman, and K. Wallendszus Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial Lancet 376 2010 1658 1669
3. S. Erqou, S. Kaptoge, and P.L. Perry Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality JAMA 302 2009 412 423
4. B.G. Nordestgaard, M.J. Chapman, and K. Ray Lipoprotein(a) as a cardiovascular risk factor: current status Eur Heart J 31 2010 2844 2853
5. S. Bohl, U. Kassner, and R. Eckardt Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress/rest perfusion magnetic resonance imaging Ther Apher Dial 13 2009 129 137
6. B.R. Jaeger, Y. Richter, and D. Nagel Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events Nat Clin Pract Cardiovasc Med 6 2009 229 239
7. S. Archontakis, A. Pottle, and N. Hakim LDL-apheresis: indications and clinical experience in a tertiary cardiac centre Int J Clin Pract 61 2007 1834 1842 (Pubitemid 47573084)